Table of Content


Chapter 1. Global Anti-Cancer Drug Market Executive Summary
1.1. Global Anti-Cancer Drug Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Indication
1.3.2. By Drug & Route of Administration
1.3.3. By End-Users
1.3.4. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Anti-Cancer Drug Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Payer/Provider Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Demographic Shifts
2.3.4.4. Physician & Patient Adoption
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Anti-Cancer Drug Market Dynamics
3.1. Market Drivers
3.1.1. Rising Global Cancer Incidence and Aging Population
3.1.2. Breakthroughs in Immunotherapy and Precision Oncology
3.1.3. Increased R&D Investment and Government Funding
3.2. Market Challenges
3.2.1. High Cost of Novel Therapies and Reimbursement Hurdles
3.2.2. Stringent Regulatory Requirements and Approval Delays
3.3. Market Opportunities
3.3.1. Expansion of Biosimilars and Generics
3.3.2. Growth in Emerging Markets with Improving Healthcare Infrastructure
3.3.3. Digital Health Integration for Patient Monitoring and Adherence
Chapter 4. Global Anti-Cancer Drug Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Future Outlook on Porter’s Model
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Anti-Cancer Drug Market Size & Forecasts by Indication 2022-2032
5.1. Segment Dashboard
5.2. Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Breast Cancer
5.2.2. Blood Cancer
5.2.3. Prostate Cancer
5.2.4. Gastrointestinal Cancer
5.2.5. Gynecologic Cancer
5.2.6. Lung Cancer
5.2.7. Others
Chapter 6. Global Anti-Cancer Drug Market Size & Forecasts by Drug & Route of Administration 2022-2032
6.1. Segment Dashboard
6.2. Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Cytotoxics
6.2.2. Hormonal Therapy
6.2.3. Targeted Therapy
6.2.4. Others
6.3. Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.3.1. Oral
6.3.2. Parenteral
6.3.3. Others
Chapter 7. Global Anti-Cancer Drug Market Size & Forecasts by End-Users 2022-2032
7.1. Segment Dashboard
7.2. End-User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospitals
7.2.2. Homecare
7.2.3. Specialty Clinics
7.2.4. Others
Chapter 8. Global Anti-Cancer Drug Market Size & Forecasts by Distribution Channel 2022-2032
8.1. Segment Dashboard
8.2. Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospital Pharmacy
8.2.2. Online Pharmacy
8.2.3. Retail Pharmacy
Chapter 9. Global Anti-Cancer Drug Market Size & Forecasts by Region 2022-2032
9.1. North America Market
9.1.1. U.S. Market
9.1.1.1. By Indication, 2022-2032
9.1.1.2. By Drug & Route, 2022-2032
9.1.2. Canada Market
9.2. Europe Market
9.2.1. UK Market
9.2.2. Germany Market
9.2.3. France Market
9.2.4. Spain Market
9.2.5. Italy Market
9.2.6. Rest of Europe Market
9.3. Asia Pacific Market
9.3.1. China Market
9.3.2. India Market
9.3.3. Japan Market
9.3.4. Australia Market
9.3.5. South Korea Market
9.3.6. Rest of Asia Pacific Market
9.4. Latin America Market
9.4.1. Brazil Market
9.4.2. Mexico Market
9.4.3. Rest of Latin America Market
9.5. Middle East & Africa Market
9.5.1. Saudi Arabia Market
9.5.2. South Africa Market
9.5.3. Rest of Middle East & Africa Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Roche Holding AG
10.1.2. Pfizer Inc.
10.1.3. Bristol Myers Squibb
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Roche Holding AG
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Pfizer Inc.
10.3.3. Bristol Myers Squibb
10.3.4. Johnson & Johnson
10.3.5. Novartis AG
10.3.6. Merck & Co., Inc.
10.3.7. AstraZeneca PLC
10.3.8. Eli Lilly and Company
Chapter 11. Research Process
11.1. Research Process Overview
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes



List of Figures

List of Figures
FIG 1. Global market research methodology
FIG 2. Global market estimation techniques
FIG 3. Market size estimates & forecast methods
FIG 4. Key oncology drug trends, 2023
FIG 5. Market growth prospects, 2022-2032
FIG 6. Porter’s Five Forces analysis
FIG 7. PESTEL analysis
FIG 8. Value chain analysis
FIG 9. Indication-wise market share, 2023 vs 2032
FIG 10. Drug class-wise market share, 2023 vs 2032
FIG 11. Route of administration-wise market share, 2023 vs 2032
FIG 12. End-user-wise market share, 2023 vs 2032
FIG 13. Distribution channel-wise market share, 2023 vs 2032
FIG 14. Regional market snapshot, 2022 vs 2032
FIG 15. North America growth, 2022-2032
FIG 16. Europe growth, 2022-2032
FIG 17. Asia Pacific growth, 2022-2032
FIG 18. Latin America growth, 2022-2032
FIG 19. Middle East & Africa growth, 2022-2032
FIG 20. Forecast sensitivity analysis, 2022-2032

List of Tables

List of Tables
TABLE 1. Global Anti-Cancer Drug market, report scope
TABLE 2. Global market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global market estimates & forecasts by Indication 2022-2032 (USD Billion)
TABLE 4. Global market estimates & forecasts by Drug Class 2022-2032 (USD Billion)
TABLE 5. Global market estimates & forecasts by Route of Administration 2022-2032 (USD Billion)
TABLE 6. Global market estimates & forecasts by End-Users 2022-2032 (USD Billion)
TABLE 7. Global market estimates & forecasts by Distribution Channel 2022-2032 (USD Billion)
TABLE 8. U.S. market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Canada market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. UK market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Germany market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. France market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Spain market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Italy market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. Rest of Europe market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. Asia Pacific market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 17. Latin America market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 18. Middle East & Africa market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Top 10 companies market share analysis, 2023 (%)
TABLE 20. Pipeline product approvals and timelines, 2023